The rise of copyright’s blockbuster initially drove a surge for pharma, however recent changes present a uncertain picture for investors. Lower-cost competitors are eroding profits, and persistent litigation add more https://larissagwil887664.weblogco.com/41472877/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-bet